![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1611, 2007-01, pp. : 17-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inpharma, Vol. 1, Iss. 1536, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
IV ibandronic acid an upcoming DIVA on the osteoporosis stage
Inpharma, Vol. 1, Iss. 1495, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Weekly ibandronic acid prevents postmenopausal bone loss
Inpharma, Vol. 1, Iss. 1406, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clodronic Acid in the Treatment of Postmenopausal Osteoporosis
Clinical Drug Investigation, Vol. 27, Iss. 6, 2007-01 ,pp. :